SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040323
Filing Date
2023-11-13
Accepted
2023-11-13 08:01:04
Documents
67
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1173652
2 ex31-1.htm EX-31.1 11357
3 ex31-2.htm EX-31.2 11359
4 ex-32.htm EX-32 6899
  Complete submission text file 0001493152-23-040323.txt   6099732

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE abeo-20230930.xsd EX-101.SCH 39580
6 XBRL CALCULATION FILE abeo-20230930_cal.xml EX-101.CAL 65052
7 XBRL DEFINITION FILE abeo-20230930_def.xml EX-101.DEF 191204
8 XBRL LABEL FILE abeo-20230930_lab.xml EX-101.LAB 369200
9 XBRL PRESENTATION FILE abeo-20230930_pre.xml EX-101.PRE 294509
61 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1020064
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 231395238
SIC: 2834 Pharmaceutical Preparations